Meditation
Meditation has been studied in 104 papers since 2014: 23 trials and 20 observational studies in people, 54 reviews; 31 in the past year. The newest paper, Nov 5, 2026: “Community interventions to reduce feelings of loneliness in older adults: a systematic review”.
2 new papers in 30 daysSee all 103 papers on meditation
At a glance
Independent labs report cognitive improvements and longer telomeres in humans practicing meditation, although other studies report no clear cognitive links or telomere-length effects. An 18-month trial shows no clear brain-age effect, and a human cohort study shows no clear overall mortality link. An author has a company affiliation, and a paper declares company ties.
97 findings in 48 papers from 2014 to 2026, 3 of them since July 2026
Independent labs found the same change in people. 27 independent labs in 18 countries; 11 trials, 2 about aging, 1 with no results posted.
“the meditation training showed no significant effect on BrainPAD within the group during the intervention nor compared to the other groups”
7 of its findings point the other way.
- 27 independent labs in 18 countries
- 7 findings against
- 11 trials, 2 about aging, 1 with no results posted
- Funders: Région Normandie and others
- 2 of 86 findings with company ties
- Human trial22
- Humans20
Studies in people
See all 13 studies of meditation in people13 studies gave meditation to people and measured what changed.
What did studies of meditation find?
55Studies of meditation measured 55 outcomes; the most studied are cognitive function (6 studies), telomere length (3) and inflammation (2).
Cognitive function
upin humans5no changein humans1upin reviews1
6 studies
Cognitive function
upin humans5no changein humans1upin reviews1
Meditation is linked with better cognitive function in humans (without self-reported depressive symptoms at baseline) (β 95% CI: 0.05, 0.40; p = 0.01).
“among those who did not have self-reported depressive symptoms at baseline, meditation ≥ twice a week was associated with improvement in cognitive outcomes such as total recall”
Humanswithout self-reported depressive symptoms at baseline2000-2016
Mindfulness
Meditation was not clearly linked with cognitive function in humans (β 95% CI: -1.01, 1.12; p = 0.92).
“meditation ≥ twice a week was not significantly associated with total recall [β; 95% CI: -0.97, 0.57; p = 0.61], global cognitive function [β; 95% CI: -1.01, 1.12; p = 0.92]”
Humans2000-2016n = 1,160
Mindfulness
Meditation improves cognitive function in humans (subjective cognitive decline, mild cognitive impairment, or Alzheimer's disease) (MD 2.22, 95% CI: 0.83-3.62, p = 0.002).
“meditation significantly improved global cognitive performance (MD 2.22, 95% CI: 0.83-3.62, p = 0.002)”
Reviewsubjective cognitive decline, mild cognitive impairment, or Alzheimer's disease
Frontiers in public health
Meditation improves cognitive function.
“Meditation practices are shown to reduce stress and improve cognitive function, further supporting healthy aging.”
Review
Experimental gerontology
Meditation improves cognitive function in humans with or without mild cognitive decline (0.643 (95% CI, 0.234-1.052)).
“meditation with 0.643 (95% CI, 0.234-1.052)”
Reviewwith or without mild cognitive decline
Preprint
Meditation improves cognitive function in humans.
“it has been shown to enhance cognitive efficiency in several domains, such as attention and executive functions in young adults.”
Review
Meditation and successful aging: can meditative practices counteract age-related cognitive decline?
Geriatrie et psychologie neuropsychiatrie du vieillissement
Meditation improves cognitive function in humans.
“meditation may be able to offset normal age-related cognitive decline or even enhance cognitive function in older adults.”
Review
The potential effects of meditation on age-related cognitive decline: a systematic review
Annals of the New York Academy of Sciences
Telomere length
upin humans2no changein humans1
3 studies
Telomere length
upin humans2no changein humans1
Meditation showed no clear effect on telomere length in humans.
“These analyses revealed significant effects of time for the 50th percentile TL (F = 80.72, padjusted <.001), i.e., a decrease in TL after the 18-month period, with no significant effect of group or group × time interactions.”
Human trial18-monthn = 137
Biological psychiatry global open science
Meditation is linked with higher telomere length in humans (meditators compared with matched non-meditators).
“Meditators had longer relative TLs (p = 0.020)”
Humansmeditators compared with matched non-meditatorsn = 30
Associations of meditation with telomere dynamics: a case-control study in healthy adults
Frontiers in psychology
Meditation increases telomere length in humans (pooled across 11 studies (12 comparisons) against control conditions) (g = .40; g = .16 with outlier trimmed).
“An overall significant weighted effect size of g =.40 indicated that the individuals in meditation conditions had longer telomeres.”
Reviewpooled across 11 studies (12 comparisons) against control conditions
Meditation and telomere length: a meta-analysis
Psychology & health
Inflammation
downin humans1downin reviews1
2 studies
Inflammation
downin humans1downin reviews1
Meditation decreases inflammation in humans.
“meditation practices have been shown to reduce stress reactivity and inflammatory responses related to cortisol secretion”
Review
Longevity, Centenarians, and Lifestyle: Any ''Tips'' to Live Longer?
Current nutrition reports
Meditation decreases inflammation.
“Evidence suggests that meditation may affect telomere dynamics by reducing stress and inflammation and improving emotional regulation.”
Review
Yoga and Telomeres: A Path to Cellular Longevity?
Cureus
Depressive symptoms
no changein humans1downin humans1
2 studies
Depressive symptoms
no changein humans1downin humans1
Meditation showed no clear effect on depressive symptoms in humans (subjective cognitive decline, mild cognitive impairment, or Alzheimer's disease) (SMD -0.16, 95% CI: -0.63 to 0.31, p = 0.514).
“no significant effect was observed on depression compared to the control group (SMD -0.16, 95% CI: -0.63 to 0.31, p = 0.514)”
Reviewsubjective cognitive decline, mild cognitive impairment, or Alzheimer's disease
Frontiers in public health
Meditation decreases depressive symptoms in humans (poor sleep quality) (SMD = -1.60, 95% CI [-1.89, 0.23], P = 0.005).
“depression (SMD=-1.60, 95% CI [-1.89, 0.23], P=0.005)”
Reviewpoor sleep quality
Behavioral sleep medicine
Sleep quality
upin humans2
2 studies
Sleep quality
upin humans2
Meditation improves sleep quality in humans (subjective cognitive decline, mild cognitive impairment, or Alzheimer's disease) (MD -1.40, 95% CI: -2.52 to -0.27, p = 0.015).
“sleep quality (MD -1.40, 95% CI: -2.52 to -0.27, p = 0.015)”
Reviewsubjective cognitive decline, mild cognitive impairment, or Alzheimer's disease
Frontiers in public health
Meditation improves sleep quality in humans (poor sleep quality) (SMD = -0.66, 95% CI [-0.894, -0.426], P < 0.00001).
“Compared to the control group, there was a significant improvement in sleep quality (SMD= -0.66, 95%CI [-0.894, -0.426], P<0.00001)”
Reviewpoor sleep quality
Behavioral sleep medicine
Executive function
no changein humans2
2 studies
Executive function
no changein humans2
Meditation was not clearly linked with executive function in humans.
“We did not observe group differences on attentional, executive and global cognitive scores or on ASQ internal score and CDS total score.”
Humans
Examining cognitive differences in expert meditators and non-meditators older adults
Scientific reports
Meditation was not clearly linked with executive function in humans.
“no such effects were found for executive function”
Humanspersistent meditation practice in both waves10 yearsn = 2,168
Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society
BrainPAD
downin humans1no changein humans1
1 study
BrainPAD
downin humans1no changein humans1
Meditation showed no clear effect on BrainPAD in humans.
“the meditation training showed no significant effect on BrainPAD within the group during the intervention nor compared to the other groups”
Human trial18-monthn = 137
Scientific reports
Meditation is linked with lower BrainPAD in humans (F = 4.26, p = 0.041).
“OldExpMed had a significantly lower/more negative BrainPAD compared to CUOA (F = 4.26, p = 0.041).”
Humans18-month
Scientific reports
Meditation is linked with lower BrainPAD in humans (long-term practice (> 20 years)).
“Compared to CUOA, OldExpMed exhibited significantly lower/more negative BrainPAD, linked to meditation hours, mental imagery, and prosocialness.”
Humanslong-term practice (> 20 years)
Scientific reports
Time spent in strongly connected state
upin humans1
1 study
Time spent in strongly connected state
upin humans1
Meditation increases time spent in strongly connected state in humans.
“The meditation training group showed a decrease, from baseline to post-intervention, in the total time spent in the “weakly connected” state (Cohen’s d [95% confidence interval], -0.44 [-0.8, -0.07]) and an increase in the total time spent in the “strongly connected” state (0.46 [0.01, 0.91]), while no change was found for time spent in the “SN-negatively connected” state (0.06 [-0.31, 0.44]) and “DMN-negatively connected” state (0.16 [-0.21, 0.54”
Human trial18-monthn = 137
Imaging neuroscience (Cambridge, Mass.)
Meditation increases time spent in strongly connected state in humans (healthy older adults) (p = 0.03, d = 0.46).
“and more time in the "strongly connected" state (p = 0.03, d = 0.46)”
Human trialhealthy older adults18-monthn = 124
Imaging neuroscience (Cambridge, Mass.)
Time spent in weakly connected state
downin humans1
1 study
Time spent in weakly connected state
downin humans1
Meditation decreases time spent in weakly connected state in humans.
“The meditation training group showed a decrease, from baseline to post-intervention, in the total time spent in the “weakly connected” state (Cohen’s d [95% confidence interval], -0.44 [-0.8, -0.07]) and an increase in the total time spent in the “strongly connected” state (0.46 [0.01, 0.91]), while no change was found for time spent in the “SN-negatively connected” state (0.06 [-0.31, 0.44]) and “DMN-negatively connected” state (0.16 [-0.21, 0.54”
Human trial18-monthn = 137
Imaging neuroscience (Cambridge, Mass.)
Meditation decreases time spent in weakly connected state in humans (healthy older adults) (p = 0.009, d = -0.44).
“spending less time in the "weakly connected" state (p = 0.009, d = -0.44)”
Human trialhealthy older adults18-monthn = 124
Imaging neuroscience (Cambridge, Mass.)
Dynamic functional network connectivity state transitions
upin humans1
1 study
Dynamic functional network connectivity state transitions
upin humans1
Meditation increases dynamic functional network connectivity state transitions in humans.
“The meditation training group showed an increase, from baseline to post-intervention, in the number of transitions between states (Cohen’s d [confidence interval], 0.52 [0.12, 0.93]).”
Human trial18-monthn = 137
Imaging neuroscience (Cambridge, Mass.)
Meditation increases dynamic functional network connectivity state transitions in humans (healthy older adults) (p = 0.008, d = 0.52).
“Only participants in the meditation group transitioned significantly more between states (p = 0.008, d = 0.52)”
Human trialhealthy older adults18-monthn = 124
Imaging neuroscience (Cambridge, Mass.)
Diastolic blood pressure
downin humans1
1 study
Diastolic blood pressure
downin humans1
Meditation decreases diastolic blood pressure in at-risk participants with intermediate to high baseline CVD risk score (FRS > 10%) (estimate -4.19, 95% CI [-7.90;-0.48]).
“In at-risk participants with intermediate to high baseline CVD risk score (FRS > 10%), mean diastolic BP changed in the comparison group (from 80.25mmHg to 79.66mmHg), and more importantly in the meditation training group (from 82.66mmHg to 77.69mmHg), with an interaction between trial arm and visit (estimate -4.19, SE 1.90; 95% confidence interval [-7.90;-0.48], t value -2.21, p = 0.03”
Human trialin at-risk participants with intermediate to high baseline CVD risk score (FRS > 10%)18 months
BMC geriatrics
Meditation decreases diastolic blood pressure in humans (participants with intermediate to high cardiovascular risk (FRS > 10%) at baseline) (p = .03).
“meditation training was associated with a greater reduction in diastolic blood pressure than the comparison group in participants with intermediate to high cardiovascular risk (FRS > 10%) at baseline (p = .03).”
Human trialparticipants with intermediate to high cardiovascular risk (FRS > 10%) at baseline18 months
BMC geriatrics
Framingham risk score
no changein humans1
1 study
Framingham risk score
no changein humans1
Meditation showed no clear effect on Framingham risk score in humans (estimate -0.03, 95% CI [-0.08;0.03]).
“In a linear mixed-effects model using log-transformed FRS, with one missing data in each group, these between-group differences over time were not significant (estimate -0.03, SE 0.03; 95% confidence interval [-0.08;0.03], t value -0.87, p = 0.38).”
Human trial18 monthsn = 137
BMC geriatrics
Meditation showed no clear effect on Framingham risk score in humans (p = .38).
“There was no difference in FRS change after 18 months between trial arms (p = .38).”
Human trial18 monthsn = 134
BMC geriatrics
Perceived stress
downin humans1
1 study
Perceived stress
downin humans1
Meditation decreases perceived stress in humans.
“• A significant reduction in perceived stress and improved stress coping skills in the intervention group (IG).”
Human trial12 weeksn = 29
Cardiovascular diagnosis and therapy
Meditation decreases perceived stress in humans (cardiovascular disease) (F[1, 27] = 4.351, P = 0.047, f = 0.402).
“there was a significant reduction in perceived stress {F[1, 27] =4.351, P=0.047, f=0.402} and improved stress coping skills {F[1, 26] =6.790, P=0.02, f=0.511} in the IG”
Human trialcardiovascular disease12-weekn = 29
Cardiovascular diagnosis and therapy
Depression
upin humans1
1 study
Depression
upin humans1
Meditation improves depression in humans.
“Depression (P =.022) and stress (P =.027) levels were lower while EI (P =.031) levels were higher in the EXP group compared to the control group.”
Human trial3 monthsn = 38
Medicine
Meditation improves depression in humans (P < .05).
“There were significant improvements in depression, stress and EI as well as tendencies of improvement in sleep quality and anxiety, in the meditation group compared to the control group.”
Human trial3 months
Medicine
Brain volume
no changein humans1
1 study
Brain volume
no changein humans1
Meditation showed no clear effect on brain volume in humans (0.01 (98.75% CI, -0.02 to 0.05)).
“The differences in the mean volume changes over 18 months between meditation and no intervention in the ACC (0.01 [98.75% CI, −0.02 to 0.05]) or the non-native language group in the insula (0.01 [98.75% CI, −0.02 to 0.03]) were not statistically significant (P =.36 and P =.58, respectively).”
Human trialanterior cingulate cortex18-monthn = 136
JAMA neurology
Meditation showed no clear effect on brain volume in humans (0.01 [98.75% CI, -0.02 to 0.05]; P = .36).
“There were no differences in volume changes of ACC (0.01 [98.75% CI, -0.02 to 0.05]; P = .36) or insula (0.01 [98.75% CI, -0.02 to 0.03]; P = .58) between meditation and no intervention or non-native language training groups”
Human trial18-monthn = 137
JAMA neurology
All 55Fewer
What is meditation linked with?
11Studies link meditation with 11 measures, most often telomere length (5 studies).
Telomere length
upin humans4mixedin humans1
5 studies
Telomere length
upin humans4mixedin humans1
Meditation is associated with telomere length in humans (class attendance in meditation group) (r = 0.45).
“In the MG but not in the LG, the total hours of class attendance positively correlated with 50th and 20th percentile TL at V3 corrected by V1 (r = 0.45, p <.004 and r = 0.33, p =.035, respectively).”
Human trialclass attendance in meditation group18-month
Biological psychiatry global open science
Meditation is associated with telomere length in meditation training group (r = 0.45, p adjusted < .011).
“the 50th percentile TL positively correlated with class attendance time (r = 0.45, p adjusted < .011)”
Human trialin meditation training groupperipheral blood mononuclear cells18-month
Biological psychiatry global open science
Meditation predicts telomere length in humans (duration of meditation, in regression with age).
“Regression analysis showed that age (p < 0.001) and duration of meditation (p = 0.003) significantly predicted TL.”
Humansduration of meditation, in regression with age6.8 years (±3.27) on averagen = 30
Associations of meditation with telomere dynamics: a case-control study in healthy adults
Frontiers in psychology
Meditation is associated with telomere length in humans (long-term meditators compared with matched non-meditators).
“The long-term meditators had a significantly longer relative TL compared to the control group (p=0.020).”
Humanslong-term meditators compared with matched non-meditatorsleucocyte5.82 hours (±3.45) of average daily meditationover 6.8 years (±3.27)
Telomere dynamics in healthy expert meditators: a case control study
Research SquarePreprint
Meditation is associated with telomere length in humans.
“The effect of meditation on TL per se is still unclear.”
Reviewn = 615
The effects of meditation on length of telomeres in healthy individuals: a systematic review
Systematic reviews
Meditation is associated with telomere length in humans (greater number of hours of meditation (dose-response across studies)).
“Across studies, a greater number of hours of meditation among participants in meditation conditions was associated with larger effect sizes.”
Reviewgreater number of hours of meditation (dose-response across studies)greater number of hours of meditation
Meditation and telomere length: a meta-analysis
Psychology & health
Rehospitalization frequency
downin humans1mixedin humans1
1 study
Rehospitalization frequency
downin humans1mixedin humans1
Meditation is associated with rehospitalization frequency in humans.
“• Significant difference regarding the frequency of rehospitalization of IG participants in the pre-post comparison.”
Human trial12 weeksn = 29
Cardiovascular diagnosis and therapy
Meditation is associated with rehospitalization frequency in humans (cardiovascular disease) (F[1, 27] = 5.607, P = 0.03, f = 0.456).
“the frequency of rehospitalization {F[1, 27] =5.607, P=0.03, f=0.456} differed significantly in the pre-post comparison”
Human trialcardiovascular disease12-weekn = 29
Cardiovascular diagnosis and therapy
Cardiovascular mortality
downin humans1HR 0.7
1 study
Cardiovascular mortality
downin humans1HR 0.7
Meditation is associated with cardiovascular mortality in humans (hypertension, non-Hispanic Black adults) (posterior HR 0.70, Pr[HR<1]=0.96).
“posteriors under a 50%-discounted trial prior were 0.84 (All-cause mortality: Pr[HR<1]=0.89) and 0.70 (Cardiovascular mortality: Pr[HR<1]=0.96).”
Humanshypertension, non-Hispanic Black adultsn = 2,786
medRxivPreprint
Mortality
downin humans1HR 0.85
1 study
Mortality
downin humans1HR 0.85
Meditation is associated with mortality in humans (below 200% of federal poverty level) (HR 0.85 (95% CI 0.71-1.03)).
“Among individuals below 200% of the federal poverty level, HRs were 0.85 (All-cause: 95% CI 0.71-1.03) and 0.80 (Cardiovascular mortality: 95% CI 0.57-1.10)”
Humansbelow 200% of federal poverty level
medRxivPreprint
Hypertension
downin humans1OR 0.11
1 study
Hypertension
downin humans1OR 0.11
Meditation lowers the risk of hypertension in humans (OR 0.11, 95% CI [0.01–0.092]).
“Finally, the risk of becoming hypertensive between baseline and follow-up tended to be lower in participants in the meditation training group: 2.2% of participants in the meditation training group and 14.6% of participants in the comparison group had worse hypertension status at follow-up”
Human trial18 monthsn = 137
BMC geriatrics
TERT expression
upin humans1
1 study
TERT expression
upin humans1
Meditation is associated with TERT expression in humans (long-term meditators compared with controls) (TERT: 1.3-fold; TERC: 1.4-fold).
“Expression of hTERT (FC=1.3, p=0.020) and hTR (FC=1.4, p=0.029) genes showed significant up-regulation in long-term meditators compared to controls.”
Humanslong-term meditators compared with controls
Telomere dynamics in healthy expert meditators: a case control study
Research SquarePreprint
Annual gray matter loss in left and right area S32 and right area 25
downin humans1
1 study
Annual gray matter loss in left and right area S32 and right area 25
downin humans1
Meditation is associated with annual gray matter loss in left and right area s32 and right area 25 in humans (long-term meditation practitioners compared with age- and sex-matched controls).
“significantly lower rates of annual tissue loss in meditators, specifically in left and right area s32 and right area 25.”
Humanslong-term meditation practitioners compared with age- and sex-matched controlssubgenual cingulate gray matter28 male, 22 femalesn = 50
Reduced age-related gray matter loss in the subgenual cingulate cortex in long-term meditators
Brain imaging and behavior
Age-related amygdala volume loss
downin humans1
1 study
Age-related amygdala volume loss
downin humans1
Meditation is associated with age-related amygdala volume loss in humans (long-term meditators compared with sex- and age-matched healthy controls).
“the age-related volume loss of the amygdala is less pronounced in long-term meditators.”
Humanslong-term meditators compared with sex- and age-matched healthy controlsamygdala44% women in each groups
Diminished Age-Related Decline of the Amygdala in Long-Term Meditation Practitioners
Psychosomatic medicine
Affective processing
mixedin humans1
1 study
Affective processing
mixedin humans1
Meditation is associated with affective processing in humans (healthy participants; compared with relaxation training).
“eight-week meditation, but not relaxation, training 'neutralized' affective processing of positive and negative stimuli in healthy elderly participants.”
Human trialhealthy participants; compared with relaxation training8 weeks
EBioMedicine
Brain preservation
upin humans1
1 study
Brain preservation
upin humans1
Meditation is associated with brain preservation in humans (Evidence based on sparse cross-sectional analyses; causation not established).
“study outcomes suggest that meditation might be beneficial for brain preservation-both with respect to gray and white matter”
ReviewEvidence based on sparse cross-sectional analyses; causation not establishedgray and white matter
Searching for the philosopher's stone: promising links between meditation and brain preservation
Annals of the New York Academy of Sciences
All 11Fewer
Has meditation been tested in people?
2 of 11 about agingYes: 23 trials and 20 observational studies in people have been published.
Trial sponsors
2 trials335 people
Beth Israel Deaconess Medical Center
2 trials164 people
1 trial1,200 people
Children's Hospital Medical Center, Cincinnati
1 trial600 people
Orlando Regional Medical Center
1 trial142 people
University of California Los Angeles
1 trial100 people
1 trial44 people
State University of New York at Buffalo
1 trial35 people
Funding
9 grants since 2018National Institute on Aging$10.8MNational Center for Complementary and Alternative Medicine$1.2MJapan Society for the Promotion of Science¥2.3M
National Institute on AgingUniversity of California, San Francisco$24K2022–2028
Agence Nationale de la RechercheCentre de Recherche en Neurosciences de Lyon€515K2024
National Institute on AgingUniversity of California, San Francisco$525K2023–2026
National Institute on AgingUniversity of California, San Francisco$525K2023–2026
National Institute on AgingUniversity of California Los Angeles$690K2017–2024
Pilot study of Buddhist-based meditation practice for cognitive impairment in the elderly
Japan Society for the Promotion of ScienceWakayama Medical University¥2.3M2021–2025
Projecting the Potential Impact of Mindfulness-based Meditation on the Risk of Alzheimer's Disease
National Institute on Minority Health and Health DisparitiesUniversity of Georgia$384K2019–2023
Mindfulness Meditation Training in Lonely Older Adults
National Center for Complementary and Alternative MedicineCarnegie-mellon University$628K2015–2021
Meditation strategies, attention and mobility in older adults
Gouvernement du Canada | Canadian Institutes of Health ResearchWestern UniversityCA$6372018–2019
How this record changed
Summary rewritten as its findings changed.
As it read before
A human preprint reports no overall effect on mortality or cardiovascular mortality, but associations with lower cardiovascular mortality in hypertensive non-Hispanic Black adults and lower mortality below 200% of the federal poverty level. A review reports meditation reduces systolic blood pressure.
Summary written from the findings.